Skip to content

Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)

Pilot Trial of a Smartphone Smoking Cessation Application Intervention for Cancer Patients (Quit2Heal Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03600038
Acronym
Quit2Heal
Enrollment
59
Registered
2018-07-26
Start date
2018-04-02
Completion date
2019-12-01
Last updated
2019-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Smoking

Keywords

Smoking cessation, App for quitting smoking, Cancer, Oncology

Brief summary

The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.

Detailed description

Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.

Interventions

BEHAVIORALExperimental smoking cessation smartphone app

The experimental arm includes an intervention using a novel/experimental smartphone smoking cessation app.

BEHAVIORALStandard of care smoking cessation smartphone app

The control intervention uses a standard of care smartphone smoking cessation app.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
CVS Health Foundation
CollaboratorUNKNOWN
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 18 or older * diagnosed with cancer in the past 12 months * has smoked a cigarette (even a puff) in the past 30 days * interested in learning skills to quit smoking * willing to be randomly assigned to either smartphone application * resides in US * has at least daily access to their own smartphone * knows how to login and download a smartphone application from the Apple app store or Android Play app store * willing and able to read in English * not currently using cessation medications or enrolled in other smoking cessation programs, and * has never used the NCI's Quit Guide smartphone application. * willing and able to complete one follow-up survey * willing to provide email, phone, and mailing address.

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frameDescription
30-day point prevalence abstinence2 months post randomizationNo smoking in the past 30 days, as reported 2 months post treatment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026